Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy
In the ATTAIN-1 trial, adults with obesity taking the highest dose lost an average of 11.2% of body weight at 72 weeks
Reason 4: Hormones and Sweat Chemistry It is tempting to pin every new smell on your GLP-1, but hormones tell a big part of the story too
They contain plant-based compounds that researchers have studied in metabolic contexts-but these represent a fundamentally different category with different mechanisms, regulatory frameworks, and evidence standards
doi:10.1007/s11136-016-1335-1 Mari A, Hosadurg D, Martin L, Zarate-Lopez N, Passananti V, Emmanuel A
doi: 10.1021/jf301306g 18 ThornalleyPJ